Related Macular Degeneration Programs Toward FDA Engagement and IND-Enabling ActivitiesTargeting Initiation of Phase 1 ...
IRVINE, CA, UNITED STATES, March 17, 2026 /EINPresswire.com/ — Qalitex Laboratories, an ISO 17025-accredited third-party analytical testing laboratory serving pharmaceutical developers, contract ...
InvestorsHub on MSN
Acumen secures funding to advance enhanced brain delivery program
Acumen Pharmaceuticals (NASDAQ:ABOS) announced that on March 13, 2026 it agreed to sell 10,833,331 common shares at a price ...
NORTH BETHESDA, Md., March 17, 2026 /PRNewswire/ -- The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers for the 2026 ISPE Europe Annual Conference, ...
Financing demonstrates conviction in oligomer-selective approach and follows strong preclinical data, including in vitro, in vivo and non-human primate study results, that support development ...
Eledon Pharmaceuticals, Inc. is rated a Strong Buy following positive phase 2 BESTOW results for tegoprubart. Read more on ...
Determination of bioequivalence to the Reference Listed Drug is essential for approval of an Abbreviated New Drug Application ...
Acurx Pharmaceuticals Inc ACXP shares are trading sharply higher Wednesday afternoon despite a lack of company-specific news ...
Atea Pharmaceuticals (NASDAQ:AVIR) outlined progress in its hepatitis C (HCV) late-stage development program and provided an ...
Taiwan is mapping out a four-year national pharmaceutical resilience preparedness program that aims to bolster the country’s ...
Olema Pharmaceuticals (OLMA) stock plummeted 41% after Roche's Phase 3 breast cancer trial failed its primary endpoint, ...
Collaboration Integrates Stem-Cell-Derived Islets with Targeted Immune Modulation ZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd. ("NewcelX") (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results